Search
for
Sort by
Research 451–480 of 1000+
- Aromatase inhibitor therapy and hair loss among breast cancer survivors
- Fractional non-ablative laser-assisted drug delivery leads to improvement in male and female pattern hair loss
- Chapter 14 Principles of drug metabolism
- Biocompatible nanoparticles and vesicular systems in transdermal drug delivery for various skin diseases
- Drug-Induced Skin, Nail and Hair Disorders
- Identifying novel strategies for treating human hair loss disorders: Cyclosporine A suppresses the Wnt inhibitor, SFRP1, in the dermal papilla of human scalp hair follicles
- Advanced nanocarrier- and microneedle-based transdermal drug delivery strategies for skin diseases treatment
- Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study
- Inhibition of 5α-Reductase, IL-6 Secretion, and Oxidation Process of Equisetum debile Roxb. ex Vaucher Extract as Functional Food and Nutraceuticals Ingredients
- 3D printed microneedles: revamping transdermal drug delivery systems
- Network-Based Drug Repositioning: Approaches, Resources, and Research Directions
- Leydig Cell Hyperplasia and Adenomas in Mice Treated with Finasteride, a 5α-Reductase Inhibitor: A Possible Mechanism
- Pharmacological Inhibition of Stearoyl CoA Desaturase in the Skin Induces Atrophy of the Sebaceous Glands
- Selective inhibition by minoxidil of prostacyclin production by cells in culture
- Inhibition of Inflammatory Gene Expression in Keratinocytes Using a Composition Containing Carnitine, Thioctic Acid and Saw Palmetto Extract
- An Update on Drug-Induced Pigmentation
- Inhibition of Established Tuberculin Hypersensitivity by Methptrexate,
- Drug eruptions in dermatology
- Drug-induced gynecomastia: A systematic review and meta-analysis of randomized clinical trials
- Cutaneous Drug Eruptions Associated with the Use of Biologies and Cutaneous Drug Eruptions Mimicking Specific Skin Diseases
- Repositioning Old Drugs for New Battles: The Expanding Role of Drug Repurposing in Cancer, Inflammation, and Metabolic Disease.
- Therapeutic inhibition of keratinocyte TRPV3 sensory channel by local anesthetic dyclonine
- Discovery of New Drug Therapies Based on the Study of Adverse Reactions
- Performance exploration of multi-gene panels of alopecia areata susceptibility and drug-binding targets
- Treatment of Alopecia Areata with Oral JAK Inhibitor : Focusing on Clinical Outcomes with Baricitinib
- TYK2 Inhibition with Deucravacitinib Improves Clinical Outcomes and Resolves Interferon-Driven Inflammation in Lichen Planopilaris
- Liposome-based drug delivery systems for skin wound healing: a promising drug delivery strategy
- Real-world pharmacovigilance insights into drug-induced risk of alopecia
- Dermal papilla cells-conditioned medium attenuates oxidative stress-induced senescence via ferroptosis inhibition
- Therapeutic Applications of Nanoemulsion Based Drug Delivery Systems: A Review of Patents in Last Two Decades